ResearcherUniversità Cattolica del Sacro CuoreActive in the last 2 years
Veronica Ruta
Matched on ORCID iD 0000-0003-3181-7024; OpenAlex author ID A5023105649. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers
Papers 6
- Ferritin-based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient-derived organoids: A novel approach for treatment. Co-author DOI 10.1002/pro.70444↗
- U2 snRNP inhibition hampers pancreatic cancer cell viability by disrupting DNA repair proficiency and mitotic checkpoint integrity Co-author DOI 10.1186/s13046-026-03795-3↗
- Splicing dysregulation: hallmark and therapeutic opportunity in pancreatic cancer. First author DOI 10.1016/j.molmed.2024.11.007↗
- DDX21 Controls Cell Cycle Progression and Autophagy in Pancreatic Cancer Cells. First author DOI 10.3390/cancers17040570↗
- An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2024.101411↗
- RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features. First author DOI 10.3390/cells9122561↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Claudio Sette · 6 shared papers, 2020–2026 · strength 1.50
- Paper Splicing dysregulation: hallmark and therapeutic opportunity in pancreatic cancer. DOI 10.1016/j.molmed.2024.11.007↗
- Paper DDX21 Controls Cell Cycle Progression and Autophagy in Pancreatic Cancer Cells. DOI 10.3390/cancers17040570↗
- Paper Ferritin-based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient-derived organ… DOI 10.1002/pro.70444↗
- Valentina Panzeri · 5 shared papers, 2020–2026 · strength 1.07
- Paper DDX21 Controls Cell Cycle Progression and Autophagy in Pancreatic Cancer Cells. DOI 10.3390/cancers17040570↗
- Paper Ferritin-based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient-derived organ… DOI 10.1002/pro.70444↗
- Paper U2 snRNP inhibition hampers pancreatic cancer cell viability by disrupting DNA repair proficiency and mitotic checkpoin… DOI 10.1186/s13046-026-03795-3↗
- Chiara Naro · 2 shared papers, 2024–2025 · strength 0.59
- Adriana Leccese · 2 shared papers, 2024–2025 · strength 0.45
- Giuseppe Quero · 2 shared papers, 2024–2026 · strength 0.41
- Paper U2 snRNP inhibition hampers pancreatic cancer cell viability by disrupting DNA repair proficiency and mitotic checkpoin… DOI 10.1186/s13046-026-03795-3↗
- Paper An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic ca… DOI 10.1016/j.xcrm.2024.101411↗
- Annalisa Pia Abbinantefina · 1 shared paper, 2026 · strength 0.28
- Gianni Colotti · 1 shared paper, 2026 · strength 0.28
- Claudio Doglioni · 2 shared papers, 2020–2024 · strength 0.26
- Paper An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic ca… DOI 10.1016/j.xcrm.2024.101411↗
- Paper RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of … DOI 10.3390/cells9122561↗
- Lívia Archibugi · 2 shared papers, 2020–2024 · strength 0.26
- Paper An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic ca… DOI 10.1016/j.xcrm.2024.101411↗
- Paper RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of … DOI 10.3390/cells9122561↗
- Gabriele Capurso · 2 shared papers, 2020–2024 · strength 0.26
- Paper An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic ca… DOI 10.1016/j.xcrm.2024.101411↗
- Paper RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of … DOI 10.3390/cells9122561↗
- Massimo Falconi · 2 shared papers, 2020–2024 · strength 0.26
- Paper An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic ca… DOI 10.1016/j.xcrm.2024.101411↗
- Paper RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of … DOI 10.3390/cells9122561↗
- Paolo Giorgio Arcidiacono · 2 shared papers, 2020–2024 · strength 0.26
- Paper An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic ca… DOI 10.1016/j.xcrm.2024.101411↗
- Paper RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of … DOI 10.3390/cells9122561↗
- Juan Carlos López-Gil · 1 shared paper, 2026 · strength 0.25
- Ana Galván-del-Rey · 1 shared paper, 2026 · strength 0.25
- Carmen E. Guerra · 1 shared paper, 2026 · strength 0.25
- Chantal Allgöwer · 1 shared paper, 2024 · strength 0.16
- Sergio Alfieri · 1 shared paper, 2024 · strength 0.16
- Alexander Kleger · 1 shared paper, 2024 · strength 0.16
- Giampaolo Tortora · 1 shared paper, 2024 · strength 0.16
- Carmine Carbone · 1 shared paper, 2024 · strength 0.16
- Sabrina Gloria Giulia Testoni · 1 shared paper, 2020 · strength 0.10
- Maria Chiara Petrone · 1 shared paper, 2020 · strength 0.10
- Miriam Redegalli · 1 shared paper, 2020 · strength 0.10
- Gemma Rossi · 1 shared paper, 2020 · strength 0.10
- Michele Reni · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.